drugset / Trial / NCT00652028
Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to characterize the pharmacokinetic and pharmacodynamic profile of dexmedetomidine administered as an intravenous loading dose followed by a continuous intravenous infusion in pediatric subjects ages ≥2 through \<17 years old.
Timeline
- Start
- 2008-11
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | — | Intravenous |
| Background | Fentanyl | Other / unclassified | — | — |
| Background | Midazolam | Small molecule | — | — |
Indications
No indication recorded.